itaconate lipid nanoparticle
Pre-clinical- Indications
- Atherosclerosis, Cardiovascular disease
Company intelligence / Profile preview
CVPath Institute conducts basic and translational research focused on cardiovascular and vascular disease. It offers advanced diagnostic, histology, consultation, and device evaluation services. The institute maintains one of the largest biorepositories of diseased human tissue for investigative studies. It has been CAP-accredited since its founding in 2005. No clinical trial results as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CVPath Institute.